Latest Information Update: 30 Apr 2013
At a glance
- Originator Cortendo
- Class Pregnenediones
- Mechanism of Action Steroid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Metabolic syndrome
Most Recent Events
- 30 Apr 2013 Discontinued - Phase-II for Metabolic syndrome in USA (unspecified route)
- 21 Oct 2002 Phase-II clinical trials in Metabolic syndrome in USA (unspecified route)